Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 9, 2019 Off

UroGen Pharma Reports First Quarter 2019 Financial Results and Recent Corporate Developments

By BusinessWire

Recent Data Presentation Highlights Consistent Complete Response Rate and Strong Durability at Six-Months in Evaluable Patients with Low-Grade Upper Tract…

May 9, 2019 Off

IQVIA™ Institute for Human Data Science Releases 2019 Medicines Report on U.S. Drug Consumption; U.S. Rx Opioid Volume Declined 17% in 2018 – Largest Single-Year Drop Ever Recorded

By BusinessWire

Spending on all U.S. medicines increased 4.5 percent to $344 billion on a net price basis, despite lower price growth,…

May 9, 2019 Off

Rainier Therapeutics Announces Upcoming Oral and Poster Presentation on Vofatamab at AACR Bladder Cancer Conference

By BusinessWire

– Data from FIERCE-22 Phase 2 Trial in Metastatic Bladder Cancer – SAN LEANDRO, Calif.–(BUSINESS WIRE)–Rainier Therapeutics, Inc., a privately-held…

May 9, 2019 Off

Cerveau Technologies, Inc. Announces a Partnership with LuMind IDSC Foundation to Study Accumulation of Neurofibrillary Tau in Down Syndrome

By BusinessWire

BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a research collaboration with the LuMind IDSC Foundation (LuMind IDSC) involving use of Cerveau’s…

May 9, 2019 Off

Horizon Therapeutics plc Announces Tina Ventura as a Healthcare Businesswomen’s Association 2019 Luminary

By BusinessWire

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that Tina Ventura, senior vice president, investor relations, has been named a…

May 9, 2019 Off

Akebia Therapeutics Reports First Quarter 2019 Financial Results; Announces Full Enrollment of Phase 3 INNO2VATE Studies and Announces Key Executive Appointments

By BusinessWire

Net Product Revenue for Auryxia Increases to $23.1 Million for Q1’FY19, Up 12.1% from Q1’FY18; Full Enrollment of Phase 3…

May 9, 2019 Off

Global Laryngeal Cancer Therapeutics Market Outlook 2019-2023: Anticipating a CAGR of More Than 7% by 2023 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Laryngeal Cancer Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The laryngeal cancer therapeutics market…

May 9, 2019 Off

Magenta Therapeutics Presents Updated Phase 2 Clinical Data on MGTA-456 Cell Therapy at American Academy of Neurology Annual Meeting

By BusinessWire

— Six-month follow-up on patients with cerebral adrenoleukodystrophy (cALD) shows stable neurological function scores and early and persistent resolution of…

May 9, 2019 Off

Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2019 Financial Results

By BusinessWire

Alpine transitions to clinical-stage company Completed financing to fund further development of both lead programs SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc.…

May 9, 2019 Off

U.S. Food & Drug Administration Accepts Takeda’s Biologics License Application for a Subcutaneous Formulation of Vedolizumab (Entyvio®) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis

By BusinessWire

An additional treatment modality would provide more flexibility in how patients receive vedolizumab, a biologic with a gut-selective mode of…

Posts pagination

Previous 1 … 3,207 3,208 3,209 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine